Infliximab is a biologic medication widely used in the treatment of inflammatory bowel diseases like Crohn’s disease and ulcerative colitis. In Mumbai, Dr. Harshad Joshi administers infliximab therapy to patients who do not respond to standard medications, offering renewed hope for long-term control of inflammation.
This targeted therapy works by blocking tumor necrosis factor-alpha (TNF-α), a protein responsible for intestinal inflammation. Administered via intravenous infusion, it helps reduce symptoms such as abdominal pain, bleeding, and diarrhoea while promoting intestinal healing.
Infliximab has transformed the management of chronic gastrointestinal disorders, helping patients achieve remission and avoid surgery. Regular monitoring and individualized dosing ensure safety and sustained benefits.
To learn whether infliximab therapy is right for your condition, contact Dr. Harshad Joshi in Mumbai and explore advanced treatment options for IBD.
